精准医疗供应链物流市场－全球产业规模、份额、趋势、机会及预测（按类型、服务、产品、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球精准医疗供应链物流市场价值为 75.1 亿美元，预计到 2030 年将达到 142.5 亿美元，复合年增长率为 11.24%。随着肿瘤、罕见疾病和遗传疾病个人化治疗的应用日益广泛，该市场正在迅速扩张。精准医疗需要运送高度敏感的生物製剂、细胞和基因疗法以及客製化诊断——每种都需要精确、温控、时间关键和针对患者的物流解决方案。截至 2025 年，全球有超过 17,000 项与精准医疗相关的临床试验，对敏捷且合规的物流基础设施的需求激增。物流供应商越来越关注安全的逆向物流、完全可追溯性和从站点到病患的配送等能力。包括物联网感测器、区块链和即时分析在内的增强技术正在推动这一领域的创新。分散试验的兴起也推动物流模式变得更加灵活和以患者为中心，特别是对于复杂治疗方案中直接面向患者的配送。

关键市场驱动因素

细胞和基因疗法的采用率不断上升

主要市场挑战

处理个人化治疗的复杂性很高

主要市场趋势

直接面向病患（DTP）服务模式的出现

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球精准医疗供应链物流市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（临床、商业）
  • 按服务（运输、仓储、采购、其他）
  • 副产品（细胞和基因疗法（CGT）、单株抗体、核酸疗法、疫苗等）
  • 按最终用户（製药和生物製药公司、临床研究组织等）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美精准医疗供应链物流市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲精准医疗供应链物流市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太精准医疗供应链物流市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲精准医疗供应链物流市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲精准医疗供应链物流市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Almac Group Limited
• Catalent, Inc.
• Parexel International Corporation
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• DHL International GmbH
• Federal Express Corporation
• UPS Healthcare
• GXO Logistics, Inc.
• Marken Limited

第 16 章：策略建议

第17章调查会社について・免责事项

The Global Precision Medicine Supply Chain Logistics Market was valued at USD 7.51 Billion in 2024 and is projected to reach USD 14.25 Billion by 2030, registering a CAGR of 11.24%. This market is expanding rapidly due to the growing adoption of personalized treatments for oncology, rare diseases, and genetic conditions. Precision medicine demands the transportation of highly sensitive biologics, cell and gene therapies, and customized diagnostics-each requiring precise, temperature-controlled, time-critical, and patient-specific logistics solutions. With over 17,000 active precision medicine-related clinical trials worldwide as of 2025, the need for agile and compliant logistics infrastructure has surged. Logistics providers are increasingly focused on capabilities such as secure reverse logistics, full traceability, and site-to-patient delivery. Enhanced technologies-including IoT sensors, blockchain, and real-time analytics-are driving innovation in this space. The rise in decentralized trials is also pushing logistics models to be more flexible and patient-centric, especially for direct-to-patient delivery in complex therapy regimens.

Key Market Drivers

Rising Adoption of Cell and Gene Therapies

The increasing use of cell and gene therapies is a key growth driver in the Precision Medicine Supply Chain Logistics Market. These personalized treatments involve a complex, highly regulated sequence-from harvesting patient samples to lab processing and returning the final product-all under strict time and temperature constraints. In 2023 and 2024 alone, the FDA approved a total of 16 cell and gene therapy products, indicating strong regulatory momentum and growing manufacturing needs. These sensitive therapies require ultra-cold or cryogenic transport to maintain integrity, driving demand for advanced cold-chain logistics, real-time GPS monitoring, and compliance-driven documentation. Providers offering complete traceability, contingency protocols, and certified infrastructure are becoming essential partners for biopharma companies.

Key Market Challenges

High Complexity of Handling Personalized Therapies

Managing personalized therapies presents significant operational challenges in the precision medicine logistics ecosystem. Unlike standard pharmaceuticals, these treatments are custom-made for individual patients and must adhere to narrow time windows and stringent environmental controls. For instance, autologous therapies involve transporting a patient's own cells to and from a specialized facility, necessitating seamless coordination, temperature integrity, and accurate labeling throughout the chain of custody. Any error-be it in customs clearance, labeling, or timing-can jeopardize treatment viability. Each shipment must align precisely with clinical and patient schedules, leaving virtually no room for deviation and amplifying the logistical complexity.

Key Market Trends

Emergence of Direct-to-Patient (DTP) Delivery Models

The growing prominence of Direct-to-Patient (DTP) delivery models is reshaping precision medicine logistics. As therapies become increasingly individualized, delivering treatment directly to patients' homes enhances accessibility and supports decentralized clinical trials. This model improves convenience, adherence, and participation, particularly for patients in remote or mobility-limited settings. DTP logistics requires precise coordination, validated cold-chain packaging, and real-time tracking systems to maintain therapy integrity during transit. Cold chain continuity and regulatory compliance are critical, especially for sensitive biologics. Logistics providers are investing in digital infrastructure and white-glove services-such as in-person delivery, patient education, and reverse logistics-to meet these complex demands. With the continued growth of telehealth and at-home diagnostics, DTP delivery is becoming integral to modern, patient-focused precision medicine.

Key Market Players

• Almac Group Limited
• Catalent, Inc.
• Parexel International Corporation
• IQVIA Holdings Inc.
• Thermo Fisher Scientific Inc.
• DHL International GmbH
• Federal Express Corporation
• UPS Healthcare
• GXO Logistics, Inc.
• Marken Limited

Report Scope:

In this report, the Global Precision Medicine Supply Chain Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Precision Medicine Supply Chain Logistics Market, By Type:

• Clinical
• Commercial

Precision Medicine Supply Chain Logistics Market, By Service:

• Transportation
• Warehousing
• Sourcing & Procurement
• Others

Precision Medicine Supply Chain Logistics Market, By Product:

• Cell & Gene Therapies (CGT)
• Monoclonal Antibodies
• Nucleic Acid Therapies
• Vaccines
• Others

Precision Medicine Supply Chain Logistics Market, By End User:

• Pharmaceutical and Biopharmaceutical Companies
• Clinical Research Organizations
• Others

Precision Medicine Supply Chain Logistics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Precision Medicine Supply Chain Logistics Market.

Available Customizations:

Global Precision Medicine Supply Chain Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Precision Medicine Supply Chain Logistics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Clinical, Commercial)
  • 5.2.2. By Service (Transportation, Warehousing, Sourcing & Procurement, Others)
  • 5.2.3. By Product (Cell & Gene Therapies (CGT), Monoclonal Antibodies, Nucleic Acid Therapies, Vaccines, Others)
  • 5.2.4. By End User (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Precision Medicine Supply Chain Logistics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Service
  • 6.2.3. By Product
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Precision Medicine Supply Chain Logistics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Service
      • 6.3.1.2.3. By Product
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Precision Medicine Supply Chain Logistics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Service
      • 6.3.2.2.3. By Product
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Precision Medicine Supply Chain Logistics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Service
      • 6.3.3.2.3. By Product
      • 6.3.3.2.4. By End User

7. Europe Precision Medicine Supply Chain Logistics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Service
  • 7.2.3. By Product
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Service
      • 7.3.1.2.3. By Product
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Service
      • 7.3.2.2.3. By Product
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Service
      • 7.3.3.2.3. By Product
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Service
      • 7.3.4.2.3. By Product
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Precision Medicine Supply Chain Logistics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Service
      • 7.3.5.2.3. By Product
      • 7.3.5.2.4. By End User

8. Asia-Pacific Precision Medicine Supply Chain Logistics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Service
  • 8.2.3. By Product
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Service
      • 8.3.1.2.3. By Product
      • 8.3.1.2.4. By End User
  • 8.3.2. India Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Service
      • 8.3.2.2.3. By Product
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Service
      • 8.3.3.2.3. By Product
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Service
      • 8.3.4.2.3. By Product
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Precision Medicine Supply Chain Logistics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Service
      • 8.3.5.2.3. By Product
      • 8.3.5.2.4. By End User

9. South America Precision Medicine Supply Chain Logistics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Service
  • 9.2.3. By Product
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Precision Medicine Supply Chain Logistics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Service
      • 9.3.1.2.3. By Product
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Precision Medicine Supply Chain Logistics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Service
      • 9.3.2.2.3. By Product
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Precision Medicine Supply Chain Logistics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Service
      • 9.3.3.2.3. By Product
      • 9.3.3.2.4. By End User

10. Middle East and Africa Precision Medicine Supply Chain Logistics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Service
  • 10.2.3. By Product
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Precision Medicine Supply Chain Logistics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Service
      • 10.3.1.2.3. By Product
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Precision Medicine Supply Chain Logistics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Service
      • 10.3.2.2.3. By Product
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Precision Medicine Supply Chain Logistics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Service
      • 10.3.3.2.3. By Product
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Almac Group Limited
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Catalent, Inc.
• 15.3. Parexel International Corporation
• 15.4. IQVIA Holdings Inc.
• 15.5. Thermo Fisher Scientific Inc.
• 15.6. DHL International GmbH
• 15.7. Federal Express Corporation
• 15.8. UPS Healthcare
• 15.9. GXO Logistics, Inc.
• 15.10. Marken Limited

16. Strategic Recommendations

17. About Us & Disclaimer